Literature DB >> 25652897

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.

Kezheng Wang1, Dipanjan Pan2, Anne H Schmieder2, Angana Senpan2, Shelton D Caruthers2, Grace Cui2, John S Allen2, Huiying Zhang2, Baozhong Shen3, Gregory M Lanza4.   

Abstract

A high r1 relaxivity manganese-gadolinium nanocolloid (αvβ3-MnOL-Gd NC) was developed and effectively detected atherosclerotic angiogenesis in rabbits fed cholesterol-rich diets for 12 months using a clinical MRI scanner (3T). 3D mapping of neovasculature signal intensity revealed the spatial coherence and intensity of plaque angiogenic expansion, which may, with other high risk MR bioindicators, help identify high-risk patients with moderate (40% to 60%) vascular stenosis. Microscopy confirmed the predominant media and plaque distribution of fluorescent αvβ3-MnOL-Gd NC, mirroring the MR data. An expected close spatial association of αvβ3-integrin neovasculature and macrophages was noted, particularly within plaque shoulder regions. Manganese oleate bioelimination occurred via the biliary system into feces. Gd-DOTA was eliminated through the bile-fecal and renal excretion routes. αvβ3-MnOL-Gd NC offers an effective vehicle for T1w neovascular imaging in atherosclerosis. From the clinical editor: Cerebrovascular accidents are a leading cause of mortality and morbidity worldwide. The acute formation of thrombus following atherosclerotic plaque rupture has been well recognized as the etiology of stroke. The authors studied microanatomical features of vulnerable atherosclerotic plaque in this article, in an attempt to identify those with high risk of rupture. Gadolinium-manganese hybrid nanocolloid (MnOL-Gd NC) was developed as a novel contrast agent for MRI. They show that this agent is effective in providing neovascular imaging.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Atherosclerosis; Contrast media; MRI; Molecular imaging; Nanotechnology

Mesh:

Substances:

Year:  2015        PMID: 25652897      PMCID: PMC4720435          DOI: 10.1016/j.nano.2014.12.008

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  36 in total

Review 1.  Revisiting an old friend: manganese-based MRI contrast agents.

Authors:  Dipanjan Pan; Shelton D Caruthers; Angana Senpan; Ann H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-21

2.  Relaxivity of liposomal paramagnetic MRI contrast agents.

Authors:  G J Strijkers; W J M Mulder; R B van Heeswijk; P M Frederik; P Bomans; P C M M Magusin; K Nicolay
Journal:  MAGMA       Date:  2005-09-09       Impact factor: 2.310

3.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary.

Authors:  Thomas G Brott; Jonathan L Halperin; Suhny Abbara; J Michael Bacharach; John D Barr; Ruth L Bush; Christopher U Cates; Mark A Creager; Susan B Fowler; Gary Friday; Vicki S Hertzberg; E Bruce McIff; Wesley S Moore; Peter D Panagos; Thomas S Riles; Robert H Rosenwasser; Allen J Taylor
Journal:  Stroke       Date:  2011-01-31       Impact factor: 7.914

4.  Acute myocardial ischemia: MR imaging with Mn-TP.

Authors:  P W Pflugfelder; M F Wendland; W W Holt; S C Quay; D Worah; N Derugin; C B Higgins
Journal:  Radiology       Date:  1988-04       Impact factor: 11.105

5.  Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.

Authors:  Franklin D Hockett; Kirk D Wallace; Anne H Schmieder; Shelton D Caruthers; Christine T N Pham; Samuel A Wickline; Gregory M Lanza
Journal:  IEEE Trans Med Imaging       Date:  2010-08-09       Impact factor: 10.048

6.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Authors:  Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

8.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 9.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

Review 10.  Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Authors:  Hale Ersoy; Frank J Rybicki
Journal:  J Magn Reson Imaging       Date:  2007-11       Impact factor: 4.813

View more
  2 in total

1.  Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.

Authors:  Alison K Esser; Anne H Schmieder; Michael H Ross; Jingyu Xiang; Xinming Su; Grace Cui; Huiying Zhang; Xiaoxia Yang; John S Allen; Todd Williams; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Nanomedicine       Date:  2015-10-27       Impact factor: 5.307

2.  Ultrasound and magnetic resonance molecular imaging of atherosclerotic neovasculature with perfluorocarbon magnetic nanocapsules targeted against vascular endothelial growth factor receptor 2 in rats.

Authors:  Hua Chen; Lianglong Chen; Rongxi Liang; Jin Wei
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.